<i>AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care</i>
Patrick A. Williams, Sayyed K. Zaidi, Rajarshi Sengupta
Abstract
The coronavirus disease 2019 , now entering its third year, has led to major disruptions to economic stability, health care, and scientific research across the globe. To address the negative impact of COVID-19 on the cancer care continuum as well as the broader interruptions caused by the pandemic to the field of cancer research, the American Association for Cancer Research launched several initiatives. The AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care (https://www.aacr.org/professionals/ research/aacr-covid-19-and-cancer-report-2022/) is one of these initiatives that presents current evidence on the burden of COVID-19 among patients with cancer and highlights the challenges as well as future opportunities created by the pandemic in cancer research and patient care. The report concludes with a Call to Action that provides policy guidance on how to better serve the cancer community in the future. In this article, we highlight key findings of the report including how COVID-19 disrupted cancer care for patients; how cancer researchers fueled progress in fighting the pandemic; how interruptions caused by COVID-19 impacted cancer research more broadly; and how regulatory changes necessitated by to the pandemic led to a revolution in telehealth adoption and clinical trial design.